Combination of interferon-beta and the angiotensin-converting enzyme inhibitor, perindopril, attenuates murine hepatocellular carcinoma development and angiogenesis.

Source:http://linkedlifedata.com/resource/pubmed/id/14676130

Clin. Cancer Res. 2003 Dec 1 9 16 Pt 1 6038-45

Download in:

View as

Triples

General Info

PMID
14676130